Replimune Group, Inc. financial data

Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
500 Unicorn Park, Woburn, MA
State of incorporation
DE
Fiscal year end
March 31
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.13K % -23%
Debt-to-equity 27.6 % +38.6%
Return On Equity -54.8 % -27.7%
Return On Assets -43 % -20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77M shares +25.5%
Common Stock, Shares, Outstanding 77M shares +25.4%
Entity Public Float 606M USD +24.4%
Common Stock, Value, Issued 77K USD +26.2%
Weighted Average Number of Shares Outstanding, Basic 83.5M shares +25.3%
Weighted Average Number of Shares Outstanding, Diluted 83.5M shares +25.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 177M USD +3.91%
General and Administrative Expense 64.1M USD +9.17%
Operating Income (Loss) -241M USD -5.26%
Nonoperating Income (Expense) 13.3M USD -32.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -228M USD -8.86%
Income Tax Expense (Benefit) 510K USD -33%
Net Income (Loss) Attributable to Parent -228M USD -8.71%
Earnings Per Share, Basic -3.07 USD/shares +2.54%
Earnings Per Share, Diluted -3.07 USD/shares +2.54%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 172M USD +76.4%
Assets, Current 548M USD +14.3%
Property, Plant and Equipment, Net 13.6M USD +43.7%
Operating Lease, Right-of-Use Asset 4.12M USD -14.4%
Other Assets, Noncurrent 1.2M USD
Assets 604M USD +13.3%
Accounts Payable, Current 7.19M USD +84.2%
Liabilities, Current 47.9M USD +23.9%
Operating Lease, Liability, Noncurrent 3.23M USD -18.5%
Other Liabilities, Noncurrent 1.27M USD +59.6%
Liabilities 121M USD +8.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6.16M USD +30.1%
Retained Earnings (Accumulated Deficit) -874M USD -35.3%
Stockholders' Equity Attributable to Parent 482M USD +14.4%
Liabilities and Equity 604M USD +13.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.2M USD -1.19%
Net Cash Provided by (Used in) Financing Activities 96.6M USD +8645%
Net Cash Provided by (Used in) Investing Activities 29.8M USD +304%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 77M shares +25.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 77.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 174M USD +75.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.05M USD +61.1%
Deferred Tax Assets, Valuation Allowance 162M USD +42.1%
Deferred Tax Assets, Gross 173M USD +37.9%
Operating Lease, Liability 4.39M USD -14.2%
Depreciation 700K USD +16.7%
Payments to Acquire Property, Plant, and Equipment 449K USD -58%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -227M USD -8.54%
Lessee, Operating Lease, Liability, to be Paid 5.59M USD -17.7%
Property, Plant and Equipment, Gross 26.2M USD +40.2%
Operating Lease, Liability, Current 1.16M USD +0.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13M USD -3.57%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD +0.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.2M USD -28.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.08M USD -5.17%
Deferred Tax Assets, Operating Loss Carryforwards 142M USD +51.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 8.67M USD -1.03%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1M USD -7.99%
Operating Lease, Payments 152K USD -42.2%
Additional Paid in Capital 1.35B USD +27.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.27M USD +42.9%
Share-based Payment Arrangement, Expense 8.64M USD +4.83%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%